ArticleJHEP reports : innovation in hepatology2026

Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study.

Michael Schwarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.